The human gut is a complex ecosystem, and maintaining its delicate balance is crucial for overall health. Now, researchers at MIT have identified a naturally occurring protein, intelectin-2, that plays a surprisingly versatile role in defending against harmful bacteria. This discovery, published in Nature Communications, could pave the way for new treatments for gut-related illnesses and offer a potential weapon against antibiotic-resistant infections.
Intelectin-2 isn’t just a single-purpose defender; it operates on two fronts. It strengthens the protective mucus layer lining the gastrointestinal tract while simultaneously trapping and neutralizing invading bacteria. This dual action makes it a particularly promising target for therapeutic intervention, especially as antimicrobial resistance continues to grow, according to the study.
Researchers found that intelectin-2 binds to sugar molecules found both on the surface of mucins – the building blocks of mucus – and on bacterial membranes. This binding action effectively traps bacteria, slowing their growth and ultimately leading to their destruction. “What’s remarkable is that intelectin-2 operates in two complementary ways. It helps stabilize the mucus layer, and if that barrier is compromised, it can directly neutralize or restrain bacteria that begin to escape,” explains Laura Kiessling, the Novartis Professor of Chemistry at MIT and senior author of the research.
A Dual-Action Defense Mechanism
The gut’s defense system relies heavily on lectins, a class of proteins that recognize and bind to carbohydrates. The human genome encodes over 200 lectins, each with potentially unique functions. Kiessling’s lab has been focused on intelectins, a specific family of lectins, and their interaction with carbohydrates. While intelectin-1 was previously studied, its precise role remained unclear, intelectin-2 has now emerged as a key player in gut immunity.
The research team discovered that intelectin-2, in both human and mouse models, binds to galactose, a sugar commonly found in mucins. This binding strengthens the mucus barrier, providing a first line of defense against bacterial invasion. Crucially, galactose is also present on the surface of some bacterial cells, allowing intelectin-2 to directly target and neutralize pathogens. The protein disrupts bacterial cell membranes, leading to their demise, and this antimicrobial effect extends to bacteria resistant to conventional antibiotics.
Implications for Inflammatory Bowel Disease and Beyond
The potential applications of this discovery are far-reaching. In individuals with inflammatory bowel disease (IBD), levels of intelectin-2 can be abnormally high or low. Researchers suggest that restoring a balanced level of this protein could support reinforce the gut barrier and alleviate symptoms. “Our findings show just how critical it is to stabilize the mucus barrier. Looking ahead, we can imagine exploiting lectin properties to design proteins that actively reinforce that protective layer,” Kiessling stated.
Beyond IBD, intelectin-2 has demonstrated the ability to neutralize dangerous pathogens like Staphylococcus aureus and Klebsiella pneumoniae, both of which are increasingly resistant to antibiotics. This suggests a potential pathway for developing novel antimicrobial treatments that harness the body’s own immune defenses.
The research, led by Amanda Dugan, a former MIT research scientist, and Deepsing Syangtan, PhD ’24, was supported by funding from the National Institutes of Health, the National Institute of Allergy and Infectious Disease, the National Institute of General Medical Sciences, and the National Science Foundation. Additional contributors included researchers from the University of California at Davis and Harvard Medical School.
As researchers continue to unravel the complexities of the gut microbiome and the role of proteins like intelectin-2, the prospect of targeted therapies to restore gut health and combat antimicrobial resistance becomes increasingly tangible. Further investigation will focus on optimizing intelectin-2’s properties and exploring its potential as a therapeutic agent.
What are your thoughts on this new discovery? Share your comments below and help us spread the word about this exciting research!
Disclaimer: This article is for informational purposes only and should not be considered medical advice. Consult with a qualified healthcare professional for any health concerns or before making any decisions related to your health or treatment.
